Mitobrin (Tobramycin)

Tobramycin, the active ingredient in Mitobrin, is an aminoglycoside antibiotic presented as an ophthalmic preparation for subconjunctival use. It treats bacterial conjunctivitis and other ocular bacterial infections in patients requiring local therapy.

GNH USA supplies Mitobrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mitobrin is an aminoglycoside antibiotic used to manage bacterial infections of the eye.

- Bacterial conjunctivitis: eradicates the causative bacteria and reduces ocular inflammation. - Bacterial keratitis: eliminates pathogenic organisms to preserve corneal integrity. - Post‑operative ocular infection: prevents or treats bacterial contamination after eye surgery.

Adverse reactions are generally limited to the ocular surface, but systemic absorption can occur.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Excessive tearing. - Foreign body sensation. - Transient blurred vision. - Mild ocular pain.

Serious or Rare Side Effects: - Allergic reaction including anaphylaxis. - Severe ocular inflammation or corneal ulceration. - Vision loss. - Systemic ototoxicity (rare). - Nephrotoxicity (rare). - Persistent or worsening infection.

Mitobrin should be used with caution and under professional supervision.

- Renal function assessment: adjust use if severe impairment is present. - Hypersensitivity monitoring: discontinue if allergic signs appear. - Aminoglycoside allergy: avoid in patients with known reactions. - Ophthalmic supervision: ensure proper administration technique. - Concomitant nephrotoxic drugs: evaluate risk of additive toxicity. - Store at room temperature: keep in original container, protect from moisture and light.

Potential drug interactions may affect safety or efficacy.

Major Interactions (Avoid): - Systemic aminoglycosides: increased risk of nephro‑ and ototoxicity. - Loop diuretics: additive renal toxicity. - Neuromuscular blocking agents: enhanced neuromuscular blockade.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: possible renal function impact. - Vancomycin: combined nephrotoxic potential. - Other ototoxic agents (e.g., gentamicin): monitor for auditory side effects.